These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35316974)

  • 1. Untangling the difficult interplay between ischemic and hemorrhagic risk: The role of risk scores.
    Persampieri S; Castini D; Lupi A; Guazzi M
    World J Cardiol; 2022 Feb; 14(2):96-107. PubMed ID: 35316974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome.
    Raposeiras-Roubín S; Caneiro Queija B; D'Ascenzo F; Kinnaird T; Ariza-Solé A; Manzano-Fernández S; Templin C; Velicki L; Xanthopoulou I; Cerrato E; Quadri G; Rognoni A; Boccuzzi G; Montabone A; Taha S; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Flores Blanco P; Garay A; Varbella F; Tomassini F; Cobas Paz R; Cespón Fernández M; Muñoz Pousa I; Gallo D; Morbiducci U; Domínguez-Rodríguez A; Baz-Alonso JA; Calvo-Iglesias F; Valdés M; Cequier Á; Gaita F; Alexopoulos D; Íñiguez-Romo A; Abu-Assi E
    Rev Esp Cardiol (Engl Ed); 2019 Mar; 72(3):215-223. PubMed ID: 30029980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor.
    Bianco M; D'ascenzo F; Raposeiras Roubin S; Kinnaird T; Peyracchia M; Ariza-Solé A; Cerrato E; Manzano-Fernández S; Gravinese C; Templin C; Destefanis P; Velicki L; Luciano A; Xanthopoulou I; Rinaldi M; Rognoni A; Varbella F; Boccuzzi G; Omedè P; Montabone A; Bernardi A; Taha S; Rossini R; Durante A; Gili S; Magnani G; Autelli M; Grosso A; Blanco PF; Giustetto C; Garay A; Quadri G; Queija BC; Srdanovic I; Paz RC; Fernández MC; Pousa IM; Gallo D; Morbiducci U; Dominguez-Rodriguez A; Lopez-Cuenca Á; Cequier A; Alexopoulos D; Iñiguez-Romo A; Pozzi R; Assi EA; Valgimigli M
    Int J Cardiol; 2020 Feb; 301():200-206. PubMed ID: 31785951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of HAS-BLED, ORBIT, PRECISE-DAPT, and PARIS risk score for predicting long-term bleeding events in patients taking an oral anticoagulant undergoing percutaneous coronary intervention.
    Yoshida R; Ishii H; Morishima I; Tanaka A; Morita Y; Takagi K; Yoshioka N; Hirayama K; Iwakawa N; Tashiro H; Kojima H; Mitsuda T; Hitora Y; Furusawa K; Tsuboi H; Murohara T
    J Cardiol; 2019 Jun; 73(6):479-487. PubMed ID: 30598387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive validation of existing bleeding and thromboembolic scores in elderly patients with comorbid atrial fibrillation and acute coronary syndrome.
    Zhang HH; Liu Q; Zhao HJ; Yu YN; Tian LY; Zhang YY; Fu ZH; Zheng L; Zhu Y; Ma YH; Li S; Ma YY; Liu YQ
    J Geriatr Cardiol; 2023 May; 20(5):330-340. PubMed ID: 37397870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of PRECISE-DAPT Score for Predicting Bleeding Complication During Dual Antiplatelet Therapy.
    Choi SY; Kim MH; Cho YR; Sung Park J; Min Lee K; Park TH; Yun SC
    Circ Cardiovasc Interv; 2018 Dec; 11(12):e006837. PubMed ID: 30545256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding risk prediction in elderly patients managed invasively for acute coronary syndromes: External validation of the PRECISE-DAPT and PARIS scores.
    Montalto C; Crimi G; Morici N; Piatti L; Grosseto D; Sganzerla P; Tortorella G; De Rosa R; De Luca L; De Luca G; Palmerini T; Valgimigli M; Savonitto S; De Servi S
    Int J Cardiol; 2021 Apr; 328():22-28. PubMed ID: 33279593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Bleeding Risk Prediction with Dual Antiplatelet Therapy After Acute Coronary Syndromes Treated Without Revascularization.
    Marquis-Gravel G; Neely ML; Valgimigli M; Costa F; Van Klaveren D; Altner R; Bhatt DL; Armstrong PW; Fox KAA; White HD; Ohman EM; Roe MT
    Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006582. PubMed ID: 32862694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials.
    Verdoia M; Khedi E; Ceccon C; Suryapranata H; De Luca G
    Int J Cardiol; 2018 Aug; 264():30-38. PubMed ID: 29776573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Antiplatelet Therapy for Long-term Secondary Prevention of Atherosclerotic Cardiovascular Events.
    Dobesh PP; Finks SW; Trujillo TC
    Clin Ther; 2020 Oct; 42(10):2084-2097. PubMed ID: 32873416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting 1-, 3- and 5-year outcomes in patients with coronary artery disease: A comparison of available risk assessment scores.
    Zdanyte M; Wrazidlo RW; Kaltenbach S; Groga-Bada P; Gawaz M; Geisler T; Rath D
    Atherosclerosis; 2021 Feb; 318():1-7. PubMed ID: 33341519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding risk in patients with acute coronary syndrome in a Turkish population: Results from the Turkish Acute Coronary Syndrome Registry (TACSER) study.
    Avci E; Kiriş T; Akgün DE; Celik A; Akçay FA; Acar B; Kurmuş Ö; Altındag R; Safak Ö; Demirtas AO; Güzel T; Öztürk Ö; Yildirim T; Yüksek U; Ergene AO
    Eur J Clin Invest; 2020 Nov; 50(11):e13271. PubMed ID: 32592511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.
    Choi KH; Song YB; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Gwon HC; Hahn JY
    Circ Cardiovasc Interv; 2020 May; 13(5):e008530. PubMed ID: 32354228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
    Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
    Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials.
    Verdoia M; Kedhi E; Suryapranata H; Frati G; Biondi-Zoccai G; De Luca G
    J Thromb Thrombolysis; 2020 Aug; 50(2):337-354. PubMed ID: 31919736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of the GRACE discharge score on the long-term out-of-hospital coronary thrombotic events after implantation of drug-eluting stents].
    Zhao XY; Li JX; Tang XF; Xian Y; Xu JJ; Song Y; Jiang L; Xu LJ; Chen J; Zhang Y; Song L; Gao LJ; Gao Z; Zhang J; Wu Y; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):187-191. PubMed ID: 29562422
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.
    Wang HY; Mo R; Guan CD; Wang Y; Zhao YY; Xie LH; Zhang R; Cai ZX; Xu B; Dou KF
    Catheter Cardiovasc Interv; 2022 Jan; 99(1):98-113. PubMed ID: 33909311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes in Patients Stratified by PRECISE-DAPT Versus DAPT Scores After Percutaneous Coronary Interventions.
    Boudreau R; Fu AYN; Barry QS; Clifford CR; Chow A; Tran U; Simard T; Labinaz M; Dick A; Glover C; Froeschl M; Hibbert B; Russo J; Chong AY; Le May M; So DYF;
    Am J Cardiol; 2021 Dec; 161():19-25. PubMed ID: 34794614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in distribution, management and outcomes of combined ischemic-bleeding risk following acute coronary syndrome.
    Mohamed MO; Rashid M; Timmis A; Clarke S; Lawson C; Michos ED; Kwok CS; De Belder M; Valgimigli M; Mamas MA
    Int J Cardiol; 2021 Apr; 329():16-22. PubMed ID: 33388397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Assessment of Predictive Performance of PRECISE-DAPT, CRUSADE, and ACUITY Scores in Risk Stratifying 30-Day Bleeding Events.
    Kawashima H; Gao C; Takahashi K; Tomaniak M; Ono M; Hara H; Wang R; Chichareon P; Suryapranata H; Walsh S; Cotton J; Koning R; Rensing B; Wykrzykowska J; de Winter RJ; Garg S; Anderson R; Hamm C; Steg PG; Onuma Y; Serruys PW
    Thromb Haemost; 2020 Jul; 120(7):1087-1095. PubMed ID: 32572864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.